ESTRO Brachytherapy for Prostate Cancer 2018

First page Table of contents Previous page 857 Next page Last page

344 patients 46Gy/23f + 19.5GY/3f HDR vs 344 patients 3D CRT 74Gy/37f Risk group: Intermediate 41%; High 59%

Made with FlippingBook - Online catalogs